“Although individual vaccines have been developed and approved for use in humans against SARS-CoV-2 and influenza viruses, ...
The CDC ACIP recommends 2 doses of the 2024-2025 COVID-19 vaccine for those age 65+ years and 2 or more doses for immunocompromised individuals.
The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback